In the completed or ongoing clinical trials of SHR2554, the most common drug‐related TEAEs in hematology were decreased white blood cell count, thrombocytopenia, neutropenia, and hyperlipidemia, increased aspartate aminotransferase level, hypertension, elevated alanine aminotransferase, anemia, etc., whereas the non‐hematological common drug‐related TEAEs were mainly nausea and fatigue. This evidence concerns the gene GPT and neutropenia.